State Street
DAWN

State Street’s Day One Biopharmaceuticals DAWN Stock Holding History

State Street’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$61.5M Sell
2,869,876
-1,419,690
-33% -$20M ﹤0.01% 1633
2025
Q4 		$40M Buy
4,289,566
+1,049,122
+32% +$8.76M ﹤0.01% 1864
2025
Q3 		$22.8M Buy
3,240,444
+550,758
+20% +$3.79M ﹤0.01% 2160
2025
Q2 		$17.5M Sell
2,689,686
-17,013
-0.6% -$117K ﹤0.01% 2263
2025
Q1 		$21.5M Sell
2,706,699
-394,978
-13% -$4.25M ﹤0.01% 2105
2024
Q4 		$39.3M Buy
3,101,677
+277,860
+10% +$3.87M ﹤0.01% 1845
2024
Q3 		$39.3M Sell
2,823,817
-3,003
-0.1% -$42.8K ﹤0.01% 1824
2024
Q2 		$39M Sell
2,826,820
-68,063
-2% -$996K ﹤0.01% 1790
2024
Q1 		$47.8M Sell
2,894,883
-485,215
-14% -$7.26M ﹤0.01% 1749
2023
Q4 		$49.3M Buy
3,380,098
+444,179
+15% +$5.38M ﹤0.01% 1710
2023
Q3 		$36M Sell
2,935,919
-418,407
-12% -$5.46M ﹤0.01% 1811
2023
Q2 		$40.1M Buy
3,354,326
+1,097,535
+49% +$14.3M ﹤0.01% 1804
2023
Q1 		$30.2M Sell
2,256,791
-199,744
-8% -$3.9M ﹤0.01% 1964
2022
Q4 		$52.9M Buy
2,456,535
+414,797
+20% +$8.51M ﹤0.01% 1601
2022
Q3 		$40.9M Buy
2,041,738
+1,682,955
+469% +$35.8M ﹤0.01% 1744
2022
Q2 		$6.42M Buy
358,783
+142,567
+66% +$1.47M ﹤0.01% 2968
2022
Q1 		$2.15M Buy
216,216
+26,725
+14% +$353K ﹤0.01% 3540
2021
Q4 		$3.19M Buy
189,491
+65,459
+53% +$1.35M ﹤0.01% 3467
2021
Q3 		$2.94M Buy
+124,032
New +$2.97M ﹤0.01% 3500

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street's DAWN Position: Q1 2026 in Review

State Street reduced its Day One Biopharmaceuticals (DAWN) stake by 33% in Q1 2026, selling an estimated $20M and leaving 2,869,876 shares worth $61.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1633.

State Street first reported a position in DAWN in Q3 2021 and has held it in 19 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • State Street held 2,869,876 shares of Day One Biopharmaceuticals worth $61.5M as of Q1 2026.
  • State Street sold 1,419,690 Day One Biopharmaceuticals shares in Q1 2026, an estimated $20M.
  • Day One Biopharmaceuticals made up ﹤0.01% of State Street's portfolio in Q1 2026, its #1633 holding.
  • State Street first reported a position in Day One Biopharmaceuticals in Q3 2021 and has held it in 19 quarters since.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.